Artikel ; Online: The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative review.
Expert review of respiratory medicine
2023 Band 17, Heft 10, Seite(n) 919–927
Abstract: Introduction: Lower respiratory tract infections (LRTIs) are among the most frequent infections and are prone to inappropriate antibiotic treatments. This results from a limited accuracy of diagnostic tools in identifying bacterial pneumonia. Lung ... ...
Abstract | Introduction: Lower respiratory tract infections (LRTIs) are among the most frequent infections and are prone to inappropriate antibiotic treatments. This results from a limited accuracy of diagnostic tools in identifying bacterial pneumonia. Lung ultrasound (LUS) has excellent sensitivity and specificity in diagnosing pneumonia. Additionally, elevated procalcitonin (PCT) levels correlate with an increased likelihood of bacterial infection. LUS and PCT appear to be complementary in identifying patients with bacterial pneumonia who are likely to benefit from antibiotics. Areas covered: This narrative review aims to summarize the current evidence for LUS to diagnose pneumonia, for PCT to guide antibiotic therapy and the clinical value of pairing both tools. Expert opinion: LUS has excellent diagnostic accuracy for pneumonia in different settings, regardless of the examiner's experience. PCT guidance safely reduces antibiotic prescription in LRTIs. The combination of both tools has demonstrated an enhanced accuracy in the diagnosis of pneumonia, including CAP in the ED and VAP in the ICU, but randomized controlled studies need to validate the clinical impact of a combined approach. |
---|---|
Mesh-Begriff(e) | Humans ; Procalcitonin/therapeutic use ; Pneumonia/diagnostic imaging ; Pneumonia/drug therapy ; Respiratory Tract Infections/drug therapy ; Lung/diagnostic imaging ; Pneumonia, Bacterial/diagnostic imaging ; Pneumonia, Bacterial/drug therapy ; Anti-Bacterial Agents/therapeutic use ; Community-Acquired Infections/diagnostic imaging ; Community-Acquired Infections/drug therapy ; Ultrasonography ; Biomarkers |
Chemische Substanzen | Procalcitonin ; Anti-Bacterial Agents ; Biomarkers |
Sprache | Englisch |
Erscheinungsdatum | 2023-11-24 |
Erscheinungsland | England |
Dokumenttyp | Journal Article ; Review ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2479146-5 |
ISSN | 1747-6356 ; 1747-6348 |
ISSN (online) | 1747-6356 |
ISSN | 1747-6348 |
DOI | 10.1080/17476348.2023.2254232 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6963: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.